Analyzing non-invasive methods for liver lesions in cirrhosis patients
Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis
This study is testing new non-invasive imaging methods to see if they can accurately identify liver lesions in patients with cirrhosis and predict their treatment outcomes and survival.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | University Hospital, Bonn Academic / other |
| Locations | 1 site (Bonn) |
| Trial ID | NCT03746210 on ClinicalTrials.gov |
What this trial studies
This study focuses on the non-invasive characterization of focal liver lesions in patients diagnosed with liver cirrhosis. It employs multiparametric ultrasound imaging and evaluates sarcopenia parameters to assess the diagnostic accuracy and predictive value of these non-invasive methods. The primary endpoint involves comparing the results to established gold standards such as CT, MRI, or histology, while the secondary endpoint examines the predictive value concerning mortality and treatment response. All procedures follow standard care protocols.
Who should consider this trial
Good fit: Ideal candidates include adults with liver cirrhosis who have focal liver lesions.
Not a fit: Patients who do not consent to participate or are under 18 years old will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the diagnostic accuracy for liver lesions, leading to better patient management and outcomes.
How similar studies have performed: Other studies have shown promise in using non-invasive methods for liver diagnostics, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * all patients with focal liver lesions and liver cirrhosis Exclusion Criteria: * no consent * under 18 years
Where this trial is running
Bonn
- University Hospital Bonn — Bonn, Germany (Recruiting)
Study contacts
- Study coordinator: Michael Praktiknjo, MD
- Email: michael.praktiknjo@ukbonn.de
- Phone: +4922828715770
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.